Research Article
Preserving the Mucosa to the Maximum Possible Extent for Endoscopic Submucosal Dissection of Subcircumferential Superficial Esophageal Carcinoma
Table 2
The patients’ characteristics and the details of management after ESD.
| | Non-LB group | LB group | value |
| Number of patients | 7 | 18 | | Median procedure time (min) [range] | 156.0 [110–210] | 140.0 [60–340] | 0.544※※ | Median lesion size (mm) [range] | 59.5 [52–85] | 56.0 [42–82] | 0.412※※ | Median resected specimen size (mm) [range] | 67.5 [59–105] | 60.0 [47–87] | 0.363※※ | pHM x (%) | 0 (0) | 3 (16.7) | 0.724※ | pHM1 (%) | 0 (0) | 4 (22.2) | 0.558※ | Local recurrence (%) | 0 (0) | 0 (0) | | Median observation period (days) [range] | 806 [184–2512] | 763 [42–1834] | 0.288※※ | Median post-ESD period until complete epithelization (days) [range] | 105 [48–132] | 51.0 [25–76] | 0.012※※ | Number of EBD patients (%) | 4 (57.1) | 6 (33.3) | 0.490※ | Median number of EBD sessions (number) [range] | 2 [2–9] | 1 [1–8] | 0.122※※ | Median total Triamcinolone dose (mg) [range] | 220 [152–312] | 106 [40–216] | 0.008※※ | Median injection sessions (number) [range] | 5.0 [2–10] | 2.3 [1–4] | 0.025※※ |
|
|
※Fisher’s exact test; ※※Mann–Whitney U test.
|